This site is intended for managed care professionals in the U.S.
Professionals in Canada should visit CanadaCGM.com
Education for Managed Care, Pharmacy, and Payer Professionals
Source: Diabetes Therapy
Key Takeaway: Flash glucose-sensing technology use in type 2 diabetes with intensive insulin therapy results in no difference in HbA1c change and reduced hypoglycemia, thus offering a safe, effective replacement for SMBG.
Click here to access.
This activity is supported by an independent educational grant from DexCom, Inc.